Envoy Medical (COCH) Raw Materials (2022 - 2026)

Envoy Medical (COCH) has 5 years of Raw Materials data on file, last reported at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials fell 13.55% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 13.55% YoY), and the FY2025 full-year result was $1.3 million, down 8.95% from the prior year.
• Raw Materials declined to $1.2 million in Q1 2026, from $1.3 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $1.4 million in Q1 2025 to a low of $1.0 million in Q4 2022.
• A 5-year average of $1.3 million and a median of $1.3 million in 2024 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials grew 19.28% in 2024 and dropped 13.55% in 2026, its largest moves.
• Tracing COCH's Raw Materials over 5 years: stood at $1.0 million in 2022, then climbed by 15.05% to $1.2 million in 2023, then rose by 19.28% to $1.4 million in 2024, then slipped by 8.95% to $1.3 million in 2025, then retreated by 1.43% to $1.2 million in 2026.
• Business Quant data shows COCH's Raw Materials at $1.2 million in Q1 2026, $1.3 million in Q4 2025, and $1.4 million in Q3 2025.